公司资料
Organovo Holdings 股价、新闻与催化剂
- 股票代码:
- ONVO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for ONVO.
公司概览
业务概览
Organovo Holdings is a biotechnology company historically focused on 3D bioprinting and tissue-engineering concepts. Its story has been tied to tissue fabrication and the long-term promise of regenerative biology.
所在地与行业分类
Organovo is headquartered in the United States and listed on NASDAQ. It sits in regenerative biotechnology and platform science.
商业模式特征
The company depends on scientific validation, strategic focus, and the ability to convert tissue-engineering ideas into a viable business. Investors historically watched platform shifts and capital runway.
生物医药行业定位
Organovo belongs to the historical regenerative-platform bucket. It has been a long-dated science story where commercialization has been difficult to sustain.
未来催化剂
- Organovo is now largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live tissue-engineering milestone. The market is focused on residual value.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。